Literature DB >> 20618598

Explanations of risk in families without identified mutations for hereditary nonpolyposis colorectal cancer.

Anne L Ersig1, Lioness Ayres, Donald W Hadley, Laura M Koehly.   

Abstract

PURPOSE: Genetic testing for hereditary forms of cancer does not always identify a causative mutation. Little is known about personal or family response to these indeterminate results when a hereditary form of cancer is suspected. This study explored thoughts about and responses to risk for hereditary nonpolyposis colorectal cancer (HNPCC) when a family member has received indeterminate genetic test results.
DESIGN: In this qualitative study, data were gathered from index cases who received indeterminate genetic test results through a longitudinal study offering genetic counseling and testing for HNPCC. First-degree relatives of these indeterminate index cases were also invited to participate in the qualitative interview.
METHODS: Semistructured telephone interviews were conducted with index cases and their at-risk first-degree relatives. Data were analyzed using the within- and across-case method.
FINDINGS: The across-case analysis led to the development of the Awareness and Surveillance Trajectory, which describes individual interpretations of and responses to risk, based on personal and family history. Explanations of risk addressed the meaning of cancer in the family and provided context for individual interpretations. They were identified using within-case analysis and organized into a typology: innate, exceptional, idiosyncratic, and undeveloped explanations.
CONCLUSIONS: Members of families without identified HNPCC mutations vary in their explanations for, interpretations of, and responses to indeterminate genetic test results. CLINICAL RELEVANCE: Explanations of family risk and interpretations of individual risk offer healthcare providers valuable information. In combination with the Awareness and Surveillance Trajectory, assessment of these beliefs can facilitate development of individualized recommendations and strategies for possible preventive actions.

Entities:  

Mesh:

Year:  2010        PMID: 20618598      PMCID: PMC3032942          DOI: 10.1111/j.1547-5069.2010.01342.x

Source DB:  PubMed          Journal:  J Nurs Scholarsh        ISSN: 1527-6546            Impact factor:   3.176


  18 in total

1.  Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing.

Authors:  M McAllister
Journal:  Clin Genet       Date:  2003-09       Impact factor: 4.438

2.  Within-case and across-case approaches to qualitative data analysis.

Authors:  Lioness Ayres; Karen Kavanaugh; Kathleen A Knafl
Journal:  Qual Health Res       Date:  2003-07

3.  Progress in genetic testing, classification, and identification of Lynch syndrome.

Authors:  Hans F A Vasen; C Richard Boland
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

Review 4.  Nursing leadership in genomics for health and society.

Authors:  Suzanne Feetham; Elizabeth J Thomson; Ada Sue Hinshaw
Journal:  J Nurs Scholarsh       Date:  2005       Impact factor: 3.176

5.  Discovering and addressing the client's lay construct of genetic disease: an important aspect of genetic healthcare?

Authors:  Heather Skirton; Christine Eiser
Journal:  Res Theory Nurs Pract       Date:  2003       Impact factor: 0.688

Review 6.  Communicating cancer risk information: the challenges of uncertainty.

Authors:  J L Bottorff; P A Ratner; J L Johnson; C Y Lovato; S A Joab
Journal:  Patient Educ Couns       Date:  1998-01

7.  The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer.

Authors:  Lori d'Agincourt-Canning
Journal:  J Genet Couns       Date:  2005-02       Impact factor: 2.537

8.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 9.  Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.

Authors:  Noralane M Lindor; Gloria M Petersen; Donald W Hadley; Anita Y Kinney; Susan Miesfeldt; Karen H Lu; Patrick Lynch; Wylie Burke; Nancy Press
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

10.  Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information.

Authors:  Rebecca D Pentz; Susan K Peterson; Beatty Watts; Sally W Vernon; Patrick M Lynch; Laura M Koehly; Ellen R Gritz
Journal:  Genet Test       Date:  2005
View more
  3 in total

1.  Understanding patterns of health communication in families at risk for hereditary nonpolyposis colorectal cancer: examining the effect of conclusive versus indeterminate genetic test results.

Authors:  Anne L Ersig; Donald W Hadley; Laura M Koehly
Journal:  Health Commun       Date:  2011-06-24

2.  Intuition versus cognition: a qualitative exploration of how women understand and manage their increased breast cancer risk.

Authors:  Louise Heiniger; Phyllis N Butow; Margaret Charles; Melanie A Price
Journal:  J Behav Med       Date:  2015-03-28

3.  Interpretation of melanoma risk feedback in first-degree relatives of melanoma patients.

Authors:  Jennifer L Hay; Carlos Baguer; Yuelin Li; Irene Orlow; Marianne Berwick
Journal:  J Cancer Epidemiol       Date:  2012-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.